Patents by Inventor Amelia Escolano

Amelia Escolano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HIV VACCINE IMMUNOGENS
    Publication number: 20250144197
    Abstract: This disclosure provides HIV immunogens and use thereof for generating an immune response in a subject. Also disclosed is a method of isolating anti-HIV antibodies and use thereof. This disclosure further provides a method for treating or preventing a human immunodeficiency type 1 (HIV-1) infection in a subject using the disclosed HIV immunogens and/or antibodies.
    Type: Application
    Filed: January 9, 2025
    Publication date: May 8, 2025
    Inventors: Michel Nussenzweig, Pamela J. Bjorkman, Amelia Escolano, Harry Gristick
  • SYSTEMS OF SINGLE-CELL LABELING AND METHODS OF USING THE SAME
    Publication number: 20250110117
    Abstract: The disclosure provides materials and methods for permanently labeling cells by transducing cells with viruses comprising a barcode. The disclosure is based on the idea that tracking, selecting and isolating lymphocytes labeled with the barcode can facilitate identification of clonal cells responsible for antibody or antibody fragment production.
    Type: Application
    Filed: September 30, 2024
    Publication date: April 3, 2025
    Applicant: The Wistar Institute of Anatomy and Biology
    Inventor: Amelia ESCOLANO
  • HIV vaccine immunogens
    Patent number: 12239698
    Abstract: This disclosure provides HIV immunogens and use thereof for generating an immune response in a subject. Also disclosed is a method of isolating anti-HIV antibodies and use thereof. This disclosure further provides a method for treating or preventing a human immunodeficiency type 1 (HIV-1) infection in a subject using the disclosed HIV immunogens and/or antibodies.
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: March 4, 2025
    Assignees: The Rockefeller University, California Institute of Technology
    Inventors: Michel Nussenzweig, Pamela J. Bjorkman, Amelia Escolano, Harry Gristick
  • HIV VACCINE IMMUNOGENS
    Publication number: 20220031830
    Abstract: This disclosure provides HIV immunogens and use thereof for generating an immune response in a subject. Also disclosed is a method of isolating anti-HIV antibodies and use thereof. This disclosure further provides a method for treating or preventing a human immunodeficiency type 1 (HIV-1) infection in a subject using the disclosed HIV immunogens and/or antibodies.
    Type: Application
    Filed: November 27, 2019
    Publication date: February 3, 2022
    Inventors: Michel Nussenzweig, Pamela J. Bjorkman, Amelia Escolano, Harry Gristick